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Abstract Previous case–control studies have suggested a
possible increased risk of Amyotrophic Lateral Sclerosis
(ALS) with physical activity (PA), but this association has
never been studied in prospective cohort studies. We
therefore assessed the association between PA and risk of
death from ALS in the European Prospective Investigation
into Cancer and Nutrition. A total of 472,100 individuals
were included in the analysis, yielding 219 ALS deaths. At
recruitment, information on PA was collected thorough
standardised questionnaires. Total PA was expressed by the
Cambridge Physical Activity Index (CPAI) and analysed in
relation to ALS mortality, using Cox hazard models.
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Interactions with age, sex, and anthropometric measures
were assessed. Total PA was weakly inversely associated
with ALS mortality with a borderline statistically signifi-
cant trend across categories (p = 0.042), with those
physically active being 33 % less likely to die from ALS
compared to those inactive: HR = 0.67 (95 % CI
0.42–1.06). Anthropometric measures, sex, and age did not
modify the association with CPAI. The present study
shows a slightly decreased—not increased like in case–
control studies—risk of dying from ALS in those with high
levels of total PA at enrolment. This association does not
appear confounded by age, gender, anthropometry, smok-
ing, and education. Ours was the first prospective cohort
study on ALS and physical activity.
Keywords Amyotrophic Lateral Sclerosis  Physical
activity  Cohort study  EPIC study  Vigorous physical
activity  BMI
Introduction
Amyotrophic Lateral Sclerosis (ALS) is a progressive
motor disease characterised by degeneration of the upper
and lower motor neurons, with a median survival of 3 years
[1]. Cigarette smoking is the only environmental factor
which has been shown to increase the risk for this disease
in case–control and cohort studies with solid design [2–5].
The observation that ALS incidence in Italy was
increased among football players [6], recently reproduced
in USA among American Football players [7], is consistent
with the hypothesis, among others, that intense physical
activity (PA) could be a risk factor for developing ALS.
This hypothesis was firstly prompted by a US case–control
study showing an increased risk of ALS among people who
reported having participated in organised sports in high
school [8]. It is supported by another small pilot case–
control study from the USA showing an increased risk of
ALS among those reporting more leisure-time PA, and
those sweating while working [9]; by a more recent large
population-based case–control study showing that leisure-
time (but not occupational or vigorous) physical activity
was associated with ALS (although there was not a clear
dose–response relationship) [10]; and by a large popula-
tion-based case–control study in Japan showing doubled
risk of ALS among those practicing vigorous physical
activity compared to physically inactive [11]. Conversely,
a previous Dutch case–control study did not observe an
association between PA and ALS: there was a younger age
of symptom onset among those with a higher cumulative
leisure PA [12]; although this was potentially explained by
a birth cohort effect [13]. A very recent large case–control
study found an inverse association between physical
activity and ALS [14]. The main epidemiological obser-
vations to date on physical activity and ALS are sum-
marised in Table 1.
Hypotheses other than that of an association between PA
and ALS which are indicated by the evidence produced so
far include: (1) that participating in sports (and not PA per
se) can increase the risk of ALS (for example via repeated
head or limb traumas, or ingestion of illicit substances
enhancing sportive performance); or (2) that the age when
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Table 1 Summary of current epidemiological evidence investigating the association between physical activity and Amyotrophic Lateral
Sclerosis
References Setting
Study design
Sample Main association Confounders
Pupillo
et al. [14]
Europe
Population-based case–control
study
652 ALS cases and 1166
controls
Total PA
OR 0.65 (0.48–0.89)
Models adjusted for age,
education, BMI, register,
interview, traumatic events,
coffee, alcohol, smoking, and
work-related PA
Yu et al.
[15]a
Michigan (USA)
Case–control study (controls
recruited through health-
related website)
66 ALS cases and 66
matched controls (sex
and age)
High PA intensity in the past
30 years OR 5.98
(0.38–93.3)
Gotkine
et al.
[16]b
Jerusalem, Israel
Comparison of self-reported
exposure to Triathlon in a
case series with nationwide
number of participants in the
total population
185 cases of ALS and total
Israeli population in
2011 (3,493,700)
OR for participation in
triathlon 16.2 (5.6–36.4)
–
Huisman
et al.
[10]c
The Netherlands
Population-based case–control
study
636 ALS cases and 2166
controls
Total PA adjusted OR 1.02
(0.98–1.06)
Leisure time PA OR 1.08
(1.02–1.14)
Occupational PA OR 1.00
(0.96–1.04)
Vigorous PA OR 1.24
(0.96–1.61)
Models adjusted for gender, age,
BMI, current smoking, current
alcohol consumption, and level
of education
Lehman
et al. [7]
USA
Standardised mortality ratios
among professional
American Football players
7 ALS deaths among 3439
American football
players
SMR 4.31 (1.73–8.87)
Vanacore
et al. [17]
USA
Case–control study on the US
mortality dataset
14,628 ALS deaths and
58,512 matched controls
(age, gender and
geographic area)
OR for intense PA at work
0.95 (99 % CI 0.86–1.04) in
men and 1.00 (99 % CI
0.82–1.20) in women
Chio’ et al.
[18]d
Italy
Standardised mortality ratios
among football, basketball
player and road cyclist
8 ALS cases among 7325
football players; no ALS
cases among 1973
basketball players and
1701 road cyclists
SMR for football players 6.45
(95 % CI 2.78–12.70)
Okamoto
et al. [11]
Japan
Population-based case control
study
183 ALS cases and 366
matched controls (age
and gender)
Vigorous physical activity
OR 2.0 (95 % CI 1.0–4.0)
Age, sex, bone fracture, ‘‘hate to
lose personality’’, self-reported
stress, type A personality,
smoking, alcohol, intake of
green/yellow vegetables
Chio’ et al.
[6]
Italy
Standardised mortality ratios
among football players
5 ALS cases among 7325
football players
SMR 6.5 (95 % CI 2.1–15.1)
Valenti
et al. [19]
Italy
Population-based case–control
study
300 ALS cases and 300
matched controls (age
and sex)
Any sport OR 0.38 (95 % CI
0.25–0.58)
Veldink
et al. [12]
Netherlands
Case–control study (cases
chose their own controls)
219 ALS cases and 254
controls
Cumulative occupational PA
OR 4th versus 1st quartile
1.07 (estimated 95 % CI
0.9–4.0)
Cumulative leisure PA OR
4th versus 1st quartile 0.8
(estimated 95 % CI
0.6–1.8)
Sex, age, level of education,
smoking, alcohol use, and
premorbid body mass index
(BMI)
Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study 257
123
physical activity is undertaken modifies the risk of ALS.
On the other hand, being lean and athletic might be a
phenotypic expression of genetic susceptibility to ALS;
this might be supported by the finding that cardiovascular
fitness was found to be associated with ALS in a record
linkage study [21]. To our knowledge, the association
between PA and risk of ALS has never been investigated in
a prospective study.
In a recent report from the EPIC cohort, a lower body
mass index (BMI) in men and a lower waist-to-hip ratio
(WHR) in women were associated with an increased risk of
dying from ALS [22]. Similar results of a decreased risk in
both men and women with increased BMI were recently
reported in five US cohorts [23]. To what extent this
association is modified by PA has not been explored so far.
The aims of this study are to: (1) assess the association
between total PA and risk of death from ALS in the
European Prospective Investigation into Cancer and
Nutrition (EPIC); (2) explore the contribution of other
cumulative measures of PA (occupational, household,
recreational, potentially traumatic, practising sports, and
vigorous PA) on the risk of ALS; and (3) investigate to
what extent these associations are confounded or modified
by anthropometric measures or other factors (sex and age).
Table 1 continued
References Setting
Study design
Sample Main association Confounders
Scarmeas
et al. [20]
New York (USA)
Hospital-based case–control
study (controls with other
neurological diseases)
431 ALS cases and 152
controls (but analyses
based on smaller
numbers)
Varsity athlete
OR 1.89 (95 % CI 1.05–3.40)
Based on 232 cases and 121
controls
Age, sex, always slim, BMI
Longstreth
et al. [8]
Washington (USA)
Washington state
Population-based case–control
study
174 ALS cases and 348
matched controls (sex
and age)
Lifetime PA in the workplace
OR 3rd versus 1st tertile
1.07 (95 % CI 0.57–2.03)
Lifetime leisure PA OR 3rd
versus 1st tertile 1.46 (95 %
CI 0.89–2.39)
Participation in organised
sports during high school
OR 1.52 (95 % CI
1.03–2.25)
Education
Strickland
et al. [9]
Minnesota (USA)
Semi-population-based semi-
hospital-based case–control
study
25 ALS cases and 50
controls: 25 hospital-
based and 25 population-
based
Having received recognition
for organised sport
participation at school OR
30 (95 % CI 1.04–9.30)
How often did PA case you to
sweat at work in your
twenties OR for trend
across 5 categories 1.60
(95 % CI 1.1–2.4)
How often did you sweat
during leisure time PA in
your twenties OR for trend
across 5 categories 1.60
(95 % CI 1.1–2.5)
a Single sports (jogging/running, cycling, swimming, aerobic dancing, recreational dancing, calisthenics, gardening, weightlifting, soccer,
football, baseball, field hockey, golf, ice hockey, tennis, boxing, wrestling) also tested yielding to non-significant differences between cases and
controls
b Severe flaws in the study as the study design is not appropriate and prevalence of triathlon in the general population is likely to be
overestimated (ever registered with the triathlon association)
c None of the variables were associated with ALS survival
d Data on football players are an update of the study published on Brain 2005; 128: 472–476
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Methods
Participants
The EPIC study was approved by the ethical committee of
the International Agency for Research on Cancer (IARC)
and by the ethics committees of each participating centre; all
participants signed an informed consent. Ninety-one percent
of the 518,408 participants were aged 35–70 years and were
recruited from the general population residing in defined
geographical areas between 1992 and 2002, in 23 centres
across 10 Western European countries (Norway, Sweden,
Denmark, United Kingdom, Netherlands, Germany, France,
Spain, Italy, and Greece) [24]. Exceptions were the French
cohort (based on women members of the health insurance
for state school), the Ragusa (Italy) cohort (based on blood
donors and their spouses), the Utrecht (Netherlands) and
Florence (Italy) cohorts (based on breast cancer screening
participants), and part of the Oxford (UK) cohort (based on
vegetarians and vegans) [24]. The Norway, France, Naples
(Italy), and Utrecht cohorts were restricted to women.
At recruitment, information on lifestyle and dietary
habits was collected through standardised questionnaires
and anthropometric characteristics were measured. Follow-
up for mortality and specific causes of death is carried out
actively or through linkage with mortality registries at
regional and national levels [24]. To date, follow-up is
98.5 % complete. The Norwegian EPIC sub-cohort
(n = 37,185) was excluded from the present analysis
because it did not give rise to any ALS cases, given its
younger age composition.
Information on mortality and causes of death was col-
lected independently: follow-up time was censored in case
of dropout, loss of follow-up or fatal events other than ALS
death (whichever occurred first). Each EPIC centre had a
different last date of follow-up, based on when a drop in
the number of reported causes of death was observed, for
minimising false negatives [22]. This resulted in censoring
follow-up time at some stage between June 2005 and June
2009, generating 5,815,773 person-years for 472,100 sub-
jects after excluding 9123 (1.9 %) individuals with missing
data on exposure or confounding variables.
Case ascertainment
ALS cases were defined as those subjects for whom ‘‘motor
neuron disease’’ (G12.2 according to the 10th revision of the
International Statistical Classification of Diseases, Injuries
and Causes of Death) was reported as an immediate, ante-
cedent or underlying cause of death (for more details, see [2]).
Physical activity assessment
The assessment of PA measures is described in detail
elsewhere [24, 25]. In brief, participants replied to a
questionnaire at baseline about occupational PA, and
recreational PA, including duration and frequency of
walking, cycling, gardening (average values in summer and
winter), household work, do-it-yourself (DIY) activities,
and sports during the previous year.
Total PA was investigated using the Cambridge Physical
Activity Index (CPAI), which combines occupational PA
(sedentary occupation, standing occupation, manual/heavy
manual work) with time participating in sports and spent
cycling [26]. The total hours per week spent cycling or
participating in sports was categorised in four levels (no,
B3.5 h/week;[3.5 and B7.0 h/week;[7.0 h/week); based
on a 4 9 4 matrix, participants were then classified in four
final categories: inactive (sedentary job, no leisure time
PA); moderately inactive (standing occupation and no lei-
sure time PA or sedentary occupation and B3.5 h/week of
leisure time PA); moderately active (manual occupation
and no leisure time PA, or standing occupation and B3.5 h/
week of leisure time PA, or sedentary occupation and[3.5
but B7 h/week of leisure time PA): and active (sedentary
job with[7 h/week of leisure time PA, or standing job and
[3.5 h/week of leisure time PA, or manual job and any
leisure time PA, or heavy manual job) [26]. The index was
developed by comparing the EPIC PA questionnaire with
objective measures of cardio-respiratory fitness and energy
expenditure assessed by heart-rate monitoring with indi-
vidual calibration (measures validated against gold stan-
dard techniques) [26], and recently revalidated against a
brief questionnaire examining energy expenditure and time
spent in moderate and vigorous physical activity [27].
Information on housework, DIY, gardening and climb-
ing stairs was combined to estimate the overall amount of
household activity. Recreational PA included walking,
cycling, gardening, sports, and DIY. Potentially traumatic
PA was defined as performing manual or heavy manual
work, playing sport, or doing DIY. Duration and frequency
were directly estimated, and intensity (i.e. energy expen-
diture) was estimated by assigning metabolic equivalents
(METs), ranging from 3 for walking and household activ-
ities to 6 for sports [28]. Household and recreational PA
were categorised in quartiles of distribution; playing sports
was categorized as 0, \12 (below the median) or 12?
(above the median) MET-h/week; vigorous PA was cate-
gorized as 0, B2 (below the median), or [2 (above the
median) h/week; potentially traumatic PA was classified as
ever/never.
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Statistical analysis
Cox proportional hazard models, with age as the main time
variable were used to investigate the associations between
type and amount of PA and ALS mortality. Hazard ratio
(HR) estimates were derived for the entire sample, strati-
fied by age and centre of recruitment. Potential con-
founders included sex, highest level of education attained
(none/primary, technical, secondary, university, undeter-
mined), a composite smoking variable (never smoker,
former smoker C10 years prior to enrolment; former
smoker\10 years prior to enrolment, current smoker 1–4
cigarettes/day; 5–14 cigarettes/day, 15–24 cigarettes/day,
C25 cigarettes/day, undetermined), BMI in units (kg/m2)
and WHR. This composite smoking variable best takes into
account the complex pattern of smoking variables on ALS
risk found in this cohort [22].
For each Cox regression analysis, a p value for linear
trend across categories was calculated by introducing the
ordinal variable in the model. The p value for interaction
between each PA category and sex, age (\50 years and
50? years), BMI, and WHR was estimated using the log-
likelihood ratio test comparing models with and without
the interaction term (allowance made for p\ 0.100). To
further explore to what extent anthropometric measures
could act as confounders separate models were computed:
(1) including and excluding them; and (2) stratified by BMI
categories [under/normal weight (\25.0 kg/m2), over-
weight (25.0–29.9 kg/m2), and obese (C 30 kg/m2)] and
WHR sex-specific quartiles. To explore the extent to which
PA modifies the age of ALS onset, the analysis of each PA
variable was repeated among those with an age of death
from ALS \70 years (N = 120), and among those aged
70? years (N = 102).
A sensitivity analysis was conducted with models
excluding ALS cases arising during the first 3 years of
follow-up in order to minimise the potential for reverse
causation. Statistical significance was set at 5 % for two-
tailed tests.
Results
The characteristics of the cohort participants by the CPAI
are described in Table 2.
A total of 219 ALS deaths (76 men and 143 women)
arose during follow-up, with the mean follow-up period
being 13 years (SD 3 years). Men and younger people were
more likely to be physically active; a moderate association
between higher levels of PA and higher educational level,
lower BMI, and less smoking was observed (Table 2).
Total PA as estimated by the CPAI was inversely associ-
ated with ALS mortality, with a statistically significant trend
across categories (p = 0.042) in the fully adjusted model
(Table 3). Introducing BMI into the model, the statistical
significance of the linear trend was maintained (p = 0.032),
and risk estimates were slightly strengthened (p value for the
interaction with BMI = 0.318); replacing BMI with WHR,
the risk estimates were slightly reduced as was the signifi-
cance level of the linear trend (p = 0.084) (p value for the
interaction with WHR = 0.889). Hazard ratio estimates by
BMI categories and WHR quartiles are shown in Fig. 1.
The association between CPAI and ALS mortality did
not appear to be modified by gender (p interac-
tion = 0.272) or age (p interaction = 0.875). When the
main analysis was repeated after excluding those who were
unemployed at recruitment (34.7 %) (and thus a priori
classified as in a sedentary job occupation), the association
between CPAI and ALS remained of similar magnitude
although falling short of statistical significance due to the
reduction of the sample size (ALS cases = 147).
Occupational, household, recreational, potentially trau-
matic, sportive, and vigorous PAs were not associated with
ALS mortality (Table 3). Although this sample is not
powered to allow subgroup analyses, we obtained sugges-
tive results for two interactions. The association with
practising sports appeared modified by anthropometry:
those normal weight practising sports above the median
had a HR 0.77 (95 % CI 0.47–1.26) compared to those who
did not practice any sport, those overweight a HR 1.30
(0.77–2.20), and those obese a HR 1.56 (0.63–3.87)
(p value for interaction with BMI 0.098); subjects in each
quartile of WHR had a HR 0.53 (0.23–1.22), HR 0.82
(0.38–1.76), HR 1.08 (0.56–2.09), and HR 2.15 (1.08–4.31)
respectively comparing those practising sport above the
median versus those not practicing sports (p value for
interaction with WHR 0.045). These findings were not
statistically significant, possible due to small numbers; the
association with ALS appears to reverse if sports were
practised by obese people (Fig. 2). The association with
vigorous PA appeared to be modified by age at recruitment
(thus age when the exposure was assessed) (p value for
interaction = 0.048): despite the reduced sample size
(ALS cases = 31), there was a suggestion of a positive
association among those reporting vigorous activity early
in life (\50 years) HR = 3.20 (95 % CI 0.87–11.74) for
B2 h/week; and HR = 3.37 (95 % CI 0.88–12.93) for
[2 h/week); p value for trend across categories 0.070).
This association was not present among those reporting
vigorous PA later on [HR = 1.04 (95 % CI 0.67–1.62);
HR = 0.74 (95 % CI 0.44–1.26), respectively]. Models run
separately for early and late age of ALS onset showed
effect estimates comparable to those of the main analysis in
both categories (results not shown).
The sensitivity analysis involving models excluding
ALS cases arising during the first 3 years and during the
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first 5 years of follow-up showed a stronger inverse asso-
ciation between the CPAI and risk of dying from ALS
[compared to the inactive, HR for the moderately inac-
tive = 0.79 (95 % CI 0.56–1.12); HR for moderately
active = 0.60 (95 % CI 0.39–0.93); and HR for the
active = 0.65 (95 % CI 0.40–1.05), p for linear
trend = 0.027 after excluding cases arisen during the first
3 years of follow up (N = 197); the same estimates after
excluding cases arisen during the first 5 years of follow-up
are HR = 0.69 (95 % CI 0.47–1.02); HR = 0.55 (95 % CI
0.34–0.90); and HR = 0.70 (95 % CI 0.42–1.16), p for
linear trend = 0.067 (n = 162)]. All other results were
substantially unchanged, apart from the widening of the
confidence intervals due to the reduction of sample size.
Discussion
The present study shows a borderline significant inverse
dose–response relationship between total PA measured at
enrolment and subsequent risk of dying from ALS. This
association does not appear to be confounded or modified
by age, gender, or BMI, smoking, or highest level of
education attained; but it became of borderline statistical
significance once introducing WHR into model. The CPAI
was designed for ranking the participants according to their
overall PA based on heart rate monitoring, best reflecting
the amount of energy spent in physical activities [26].
This is the first prospective cohort study assessing the
type and amount of PA before disease onset, and the sub-
sequent risk of developing and dying from ALS. The
finding of an inverse association between PA and risk of
ALS is at odds with the majority of findings coming from
case–control studies [8, 10, 12, 20].
To date, in fact, all published evidence on the associa-
tion between ALS and PA comes either from case–control
studies [8, 9, 20, 29], or from retrospective cohort studies
[6, 7]. The former have the limitation of being prone to
recall bias (which might be particularly relevant when
assessing PA whose quantification is not easy, and which
can be easily related by patients to a disease impairing
movements). The retrospective cohort studies investigating
the risk of ALS among football players have the advantage
of including large numbers, but are limited to a highly
selected group, and cannot fully account for potential
confounders.
Possible ways in which PA may increase the risk of ALS
involve oxidative stress, glutamate excitotoxicity and
Table 2 Demographic and
lifestyle characteristics of the
cohort according to categories
of physical activity
(n = 472,100)
Inactive
N = 109,545
Moderately inactive
N = 161,906
Moderately active
N = 113,854
Active
N = 86,795
Gender
Men, N (%)a 29,501 (26.9) 46,110 (28.5) 36,309 (31.9) 36,315 (41.8)
Women, N (%)a 80,044 (73.1) 115,796 (71.5) 77,545 (68.1) 50,480 (58.2)
Age (years), mean (SD) 55.2 (10.6) 51.8 (9.9) 49.8 (10.0) 47.9 (12.2)
Smokingb,c
Never 58,513 (54.2) 83,126 (52.2) 56,715 (50.7) 38,598 (44.9)
Former C10 years 17,003 (15.8) 28,405 (17.8) 21,147 (18.9) 17,411 (20.3)
Former\10 years 8535 (7.9) 14,269 (9.0) 10,461 (9.4) 8912 (10.4)
Current 1–4 cig/day 2200 (2.0) 4103 (2.6) 3009 (2.7) 2542 (3.0)
Current 5–14 cig/day 7406 (6.9) 10,953 (6.9) 7671 (6.9) 6748 (7.9)
Current 15–24 cig/day 8661 (8.0) 11,394 (7.2) 7812 (7.0) 7309 (8.5)
Current 25? cig/day 5607 (5.2) 7086 (4.5) 5108 (4.6) 4457 (5.2)
BMI
Under-/normal weightb 44,599 (40.7) 85,665 (52.9) 64,251 (56.4) 46,191 (53.2)
Overweight 41,731 (38.1) 55,710 (34.4) 37,227 (32.7) 31,151 (35.9)
Obese 23,215 (21.2) 20,531 (12.7) 12,376 (10.9) 9453 (10.9)
Educationb,d
None/primary 48,254 (46.6) 44,127 (28.3) 28,557 (25.9) 25,043 (29.6)
Technical 17,768 (17.1) 32,871 (21.1) 24,167 (21.9) 24,826 (29.4)
Secondary 18,272 (17.6) 34,953 (22.4) 25,134 (22.8) 14,673 (17.4)
University 19,340 (18.7) 44,210 (28.3) 32,526 (29.5) 19,976 (23.6)
ALS cases 72 (0.07) 80 (0.05) 38 (0.003) 29 (0.03)
a Percentages in rows; b percentages in column; c smoking status unknown for 6939 individuals (1.5 %);
d unknown for 17,403 individuals (3.7 %)
Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study 261
123
complex interactions with ALS susceptibility genes [30].
On the other hand, the mechanisms through which PA
might protect against ALS are thought to be mediated by
exercise-induced changes in motor neuron morphology,
muscle-nerve interaction, glial activation, and altering
levels of gene expression of anti-apoptotic proteins and
neurotrophic factors [31]. The effects of exercise upon
astrocytes and angiogenesis are also relevant in ALS as
astrocytes play an important structural role in the mainte-
nance of the blood–brain barrier (BBB) [32]. A disruption
of the BBB in SOD1 mice was found starting in the early
stages of the disease [33]. The extensive disruption of the
neurovascular unit may promote the progressive loss of
motor neurons, with their integrity dependent upon
Table 3 HR of dying from ALS according to type of physical activity
ALS cases Adjusted HR (95 %
CI)a
Adjusted HR (95 % CI)a including
BMI
Adjusted HR (95 % CI)a including
WHR
Cambridge index of physical activity
Inactive 72 (32.9) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Moderately inactive 80 (36.5) 0.88 (0.63–1.22) 0.86 (0.62–1.20) 0.92 (0.64–1.34)
Moderately active 38 (17.4) 0.70 (0.46–1.05) 0.68 (0.45–1.03) 0.76 (0.48–1.20)
Active 29 (13.2) 0.67 (0.42–1.06) 0.65 (0.41–1.04) 0.67 (0.40–1.11)
p-trend 0.042 0.032 0.084
Occupational activity
Sedentary 28 (35.4) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Standing 34 (43.0) 1.39 (0.83–2.35) 1.39 (0.83–2.35) 1.73 (0.97–3.09)
Manual/heavy manual 17 (21.5) 1.28 (0.67–2.44) 1.28 (0.67–2.43) 1.61 (0.80–3.24)
p-trend 0.341 0.343 0.113
Household activity
1st quartile 42 (20.0) 1.00 (ref) 1.00 (ref) 1.00 (ref)
2nd quartile 69 (32.9) 1.43 (0.97–2.11) 1.43 (0.97–2.11) 1.77 (1.11–2.78)
3rd quartile 42 (20.0) 0.82 (0.52–1.27) 0.81 (0.52–1.27) 0.94 (0.57–1.56)
4th quartile 57 (27.1) 1.11 (0.72–1.70) 1.11 (0.73–1.71) 1.25 (0.77–2.02)
p-trend 0.649 0.662 0.795
Recreational activity
1st quartile 46 (21.9) 1.00 (ref) 1.00 (ref) 1.00 (ref)
2nd quartile 56 (26.7) 1.06 (0.71–1.57) 1.05 (0.70–1.55) 1.07 (0.70–1.63)
3rd quartile 59 (28.1) 1.15 (0.77–1.70) 1.13 (0.76–1.67) 0.93 (0.60–1.45)
4th quartile 49 (23.3) 0.91 (0.60–1.39) 0.89 (0.59–1.36) 0.83 (0.53–1.31)
p-trend 0.770 0.688 0.328
Practising sports
No 131 (29.8) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Below the median 36 (16.4) 0.85 (0.58–1.24) 0.84 (0.57–1.23) 0.82 (0.54–1.25)
Above the median 52 (23.7) 1.03 (0.74–1.44) 1.01 (0.72–1.41) 1.01 (0.70–1.45)
p-trend 0.985 0.921 0.899
Potentially traumatic physical activity
Never 90 (41.1) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Ever 129 (58.1) 0.93 (0.69–1.26) 0.92 (0.67–1.24) 0.91 (0.65–1.26)
Vigorous physical activity
None 96 (60.4) 1.00 (ref) 1.00 (ref) 1.00 (ref)
B2 h/week 39 (24.5) 1.16 (0.77–1.75) 1.15 (0.77–1.74) 1.05 (0.65–1.68)
[2 h/week 24 (15.1) 0.89 (0.55–1.43) 0.89 (0.55–1.43) 0.93 (0.55–1.57)
p-trend 0.789 0.769 0.833
a Model stratified by centre and age and adjusted for smoking status, highest level of education attained, and sex
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efficient capillary influx of nutrients and efflux of waste, as
well as direct supportive interactions with astrocytes. In the
brains of exercised rats, the neurovascular unit is
strengthened by increased angiogenesis and astrocyte pro-
liferation [34].
The present data suggest that reverse causality is not a
likely explanation of the results: after removing ALS
deaths during the first 3 years of follow up, the inverse
association strengthened (albeit with a reduced sample
size). The role of unemployment in contributing to the
CPAI is more complex: it might represent an effect of
residual confounding of socio-economic status, or an
unmeasured reverse causality. However, the fact that an
association of similar magnitude between CPAI and ALS
mortality (albeit not significant) is obtained after excluding
those subjects who were unemployed at recruitment sug-
gests that residual confounding or reverse causality are
perhaps not the most likely explanations.
The present study had lower statistical power to detect
interactions, and the findings in this sense should be
interpreted cautiously and regarded as hypothesis generat-
ing. Nevertheless, it is interesting that there was also a
suggestion of an increased risk of ALS from vigorous PA
in obese subjects (or subjects with an elevated BMI due to
substantial increase of muscle mass) among those practis-
ing sports, and in young individuals. Should these be
confirmed by further investigations, they may reflect some
specific characteristics of these two categories, such as, for
Fig. 1 HR and relative 95 % CI for categories of Cambridge Index of
physical activity by BMI category (a) and quartiles of WHR (b).
*p value for trend across categories p = 0.455; p value for trend
across categories p = 0.101; p value for trend across categories
p = 0.119. §p value for trend across categories p = 0.340; p value
for trend across categories p = 0.588; ^p value for trend across
categories p = 0.410; *p value for trend across categories p = 0.296
Fig. 2 HR and relative 95 % CI for categories of practising sport by
BMI categories (a) and WHR sex-specific quartiles (b). *p value for
trend across categories p = 0.345; p value for trend across categories
p = 0.633; p value for trend across categories p = 0.354. §p value
for trend across categories p = 0.150; p value for trend across
categories p = 0.577; ^p value for trend across categories p = 0.878;
*p value for trend across categories p = 0.033
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example, the use of some stimulating agents enhancing
sportive performance and/or promoting weight loss [35].
Some of these compounds, such as anabolic steroids and
testosterone, increasingly used and abused by athletes for
enhancing performance [36], have been shown to stimulate
muscle mass increase [37]. These hormones may increase
ALS risk though unknown mechanisms, and may also
contribute to the higher incidence of ALS in men than
women [38]. This hypothesis is consistent with previous
observations linking ALS risk to practising sports in gen-
eral [17, 20], or being professional football players [6, 7],
or varsity athletes [8, 9, 20] or professional athletes [17].
Also, a recent report from Europe describes an inverse
association between PA and ALS, except for professional
sport players [29, 39]. Unfortunately, we are not able to
reproduce the findings on professional sport players in this
setting, as this information is not available in EPIC. A
cohort effect explaining the suggested increased risk
among those practising vigorous PA at younger ages has
already been suggested by Ascherio [13] in reference to the
study by Veldink et al. [12]; this cannot be ruled out,
although it seems an unlikely explanation given that it
applies to vigorous activity only. The small sample size
and the relative oversampling of women by design in the
EPIC study do not allow powered estimates of association
in both sexes, separately. Despite the p value for interaction
with sex being far non-significant (p = 0.272), we cannot
rule out that the present results are at least partially driven
by the association in women.
Death records appear to be reliable for ascertaining ALS
deaths (and hence ALS itself) in this [2] and other large
population studies [40]. Nonetheless, a recent study in UK
identified an error in the WHO ICD-10 Alphabetic coding
Index where progressive supranuclear palsy was mistak-
enly given as code G12 [23]. However, a validation exer-
cise on death records demonstrated that only 8 % of the
women receiving a diagnosis of ALS were misclassified
[3]. Furthermore, misclassification introduced by the use of
death records instead of specialist diagnoses would likely
be non-differential and thus bias the estimate towards the
null; therefore the risk estimates reported here might
underestimate true associations.
In summary, in this prospective study, practising more
PA was associated with a reduced risk of dying from ALS.
This association does not appear to be confounded or
modified by age, gender, BMI, smoking and the highest
level of education attained, and it is unlikely explained by
reverse causation.
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